Coronary Embolic Protection Device Market Size, Share & COVID-19 Impact Analysis | Global | 2023–2029 | MedCore |

  • Year: 2023
  • Scope: 10 Years
  • Region: Global
  • Type: MedCore

Product Description

The global embolic protection device market size is expected to reach a market value of $73 million in 2029. In 2022, the market was valued at $80 million meaning there will be an expected decrease in market value over the forecast period at a CAGR of -1.4%,


  • Unit Sales, Average Selling Prices, Market Size & Growth Trends
  • Procedure Volumes
  • Market Drivers & Limiters
  • Market Forecasts Until 2027, and Historical Data to 2017
  • Recent Mergers & Acquisitions
  • Disease Overviews and Demographic Information
  • Company Profiles, Product Portfolios, and SWOT for Top Competitors

PROCEDURE VOLUMESProcedure Volumes for Interventional Cardiology

Through this study on the global coronary embolic protection device market, iData Research has performed an analysis on angiography, angioplasty (or PCI), atherectomy, and catheterization procedure volumes in order to increase the accuracy of our market sizing, and provide you with the volume of procedures over a 10-year range and across 70 countries.


Despite the reduction in risk associated with the use of EPDs, this cost burden has limited their overall use. Mainly for this reason, physicians have moved away from using EPDs and will continue to do so, limiting unit sales.

EPDs are not considered essential devices for interventional cardiology procedures as they are notalways covered under national reimbursement schedules. As a result, a larger adoption of the devices is not expected, leading to a small decline in the market.


Boston Scientific, Medtronic, and Abbott controlled the global coronary embolic protection device market.Top Competitors in the Coronary Embolic Protection Device MarketIn 2022, the leading competitor in the coronary EPD market was Boston Scientific. The company currently offers the FilterWire EZ™ product line, a distal filter-basket system that can be adapted to different vessel shapes and sizes, as well as the SENTINEL™ Cerebral Protection System.

Medtronic was the second-leading competitor in the coronary EPD market in 2022. The company currently offers the Mo.Ma™ Ultra proximal cerebral protection device.

In 2022, Abbott was the third-leading competitor in the coronary EPD market. The company currently offers the RX Accunet® embolic protection systems, which are used for carotid interventions and feature rapid exchange delivery


Throughout this report, iData Research has covered over 70 countries across the globe in great detail. The regions covered are:

  • North America (the United States and Canada)
  • Latin America (Brazil, Mexico, Colombia, Argentina, Peru, Chile, Venezuela, and Other)
  • Western Europe (Germany, France, Italy, Spain, Switzerland, Austria, Portugal, Benelux, Scandinavia, and Other)
  • Central and Eastern Europe (Poland, Turkey, Russia, Greece, Czech Republic, Croatia, Bulgaria, Ukraine, Kazakhstan, Hungary, Romania, Baltic States (Estonia, Latvia, and Lithuania), and Other)
  • Middle East (Saudi Arabia, UAE, Israel, Iran, Kuwait, Qatar, Bahrain, Oman, and Other)
  • Asia Pacific (China, Japan, South Korea, India, Australia, Singapore, Indonesia, Malaysia, Thailand, the Philippines, Brunei, Myanmar, Cambodia, Vietnam, New Zealand, Taiwan, Hong Kong, and Other)
  • Africa South Africa, Egypt, Morocco, Ghana, Nigeria, Libya, Sudan, Uganda, Kenya, and Other)


For full segmentation and any questions regarding research coverage, please contact us or send a request by pressing one of the buttons on the right.

FREE Sample Report

Coronary embolic protection device Market 322
10.1 Executive Summary 322
10.1.1 Global Coronary Embolic Protection Device Market Overview 322
10.1.2 Competitive Analysis 325
10.1.3 Regions Included 326
10.2 Introduction 328
10.2.1 Protection Mechanism 328 Filter Basket 328 Distal Balloon Occlusion 328
10.3 Market Analysis and Forecast 330
10.4 Drivers and Limiters 334
10.4.1 Market Drivers 334
10.4.2 Market Limiters 335
10.5 Competitive Market Share Analysis 336
Companies Included: Boston Scientific, Medtronic, Abbott, and Others
Chart 10‑1: Coronary Embolic Protection Device Market, Global, 2022 & 2029 324
Chart 10‑2: Coronary Embolic Protection Procedures, Global, 2022 324
Chart 10‑3: Leading Competitors, Coronary Embolic Protection Device Market, Global, 2022 338
Figure 10‑1: Coronary Embolic Protection Device Regions Covered, Global (1 of 2) 326
Figure 10‑2: Coronary Embolic Protection Device Regions Covered, Global (2 of 2) 327
Figure 10‑3: Coronary Embolic Protection Device Market, Global, 2019 – 2029 330
Figure 10‑4: Units Sold by Region, Coronary Embolic Protection Device Market, Global, 2019 – 2029 331
Figure 10‑5: Average Selling Price by Region, Coronary Embolic Protection Device Market, Global, 2019 – 2029 (US$) 332
Figure 10‑6: Market Value by Region, Coronary Embolic Protection Device Market, Global, 2019 – 2029 (US$M) 333
Figure 10‑7: Leading Competitors, Coronary Embolic Protection Device Market, Global, 2022 337

iData’s 9-Step Research Methodology

Our reports follow an in-depth 9-step methodology which focuses on the following research systems:

  • Original primary research that consists of the most up-to-date market data
  • Strong foundation of quantitative and qualitative research
  • Focused on the needs and strategic challenges of the industry participants

Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.

Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.

Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.

Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.

Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.

Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.

Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.

Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.

Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.

Click Here to Read More About Our Methodology

Explore Options

Report Summary


Select License Type

iData’s global coronary embolic protection device market MedCore covers both the saphenous vein graft market and the protection mechanism market. Medcores include a highly detailed and in-depth look at a segment in a market with all the associated sub- and sub-sub segments. iData MedCore reports allow users to delve deep into a specific market in order to obtain units sold, average selling prices (ASPs), market values, growth rates, a 10-year forecast including historical and future market estimates, and competitor market shares of any given market segment.

  • 2023
  • 10 Years
  • Global
  • MedCore
    Your Cart
    Your cart is emptyReturn to Report Library